DGAP-News: Hail First Pharma Inc.: Trading Halted Pending Reverse Split

DGAP-News: Hail First Pharma Inc. / Key word(s): Corporate Action
Hail First Pharma Inc.: Trading Halted Pending Reverse Split

04.05.2011 / 18:38

---------------------------------------------------------------------

Hail First Pharma Trading Halted Pending Reverse Split

Dubai - UAE - May 4, 2011 - Hail First Pharma Inc. formerly Zoloto Ventures
Corp. (Frankfurt: 499) Announced today that the Deutsche Börse has halted
trading pending the reverse split.

The name change has taken effect on April 26, 2011 and the reverse stock
split is expected to take effect the week of May 6, 2011 pending receipt of
a new ISIN number reflecting the corporate action.  The company's share
will resume trading upon the effectiveness of the reverse stock split of
10,000 to 1.

About Hail First Pharma

Hail First Pharma is a pharmaceutical company specializing in acquiring,
licensing and distributing of diabetic drugs, drug delivery technology,
nutritional products and medical equipment.

Important Information
About Forward-Looking Statements in this press release may be
'forward-looking statements' within the meaning of the Private Securities
Litigation Reform Act of 1995. Words such as 'anticipate,' 'believe,'
'estimate,' 'expect,' 'intend' and similar expressions, as they relate to
the company or its management, identify forward-looking statements. These
statements are based on current expectations, estimates and projections
about the company's business based, in part, on assumptions made by
management. These statements are not guarantees of future performance and
involve risks, uncertainties and assumptions that are difficult to predict.
Therefore, actual outcomes and results may, and probably will, differ
materially from what is expressed or forecasted in such forward-looking
statements due to numerous factors, including those described above. In
addition, such statements could be affected by risks and uncertainties
related to the exploration for and development of mineralized material,
product demand, market and customer acceptance, competition, pricing and
development difficulties, as well as general industry and market conditions
and growth rates and general economic conditions. Any forward-looking
statements speak only as of the date on which they are made, and the
company does not undertake any obligation to update any forward-looking
statement to reflect events or circumstances after the date of this
release. Information on the Company's website does not constitute a part of
this release.

Contact:
Hail First Pharma Inc.   DRG Advisors LLC

Hussain Al-Awaid    Robert Albi
Chairman     President
hailfirstpharma@gmail.com    Tel. 516-351-8562


End of Corporate News

---------------------------------------------------------------------

04.05.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


123027 04.05.2011